Follow The Filings

SLGN Silgan

Silgan earnings company data as of 11:18 PM ET 11/17

History

1 period, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 29 Oct EPS 1.25 — —
Rev $2.10B $2.04B Miss -3.0%

Insider trades

Open-market buys and sales by SLGN's executives, directors and 10% owners in the last 12 months, from their Form 4s

All SLGN insider trades
  • None no insider bought on the open market
  • $2.6M sold by 1 insider outside a trading plan
  • None no planned (10b5-1) sales
  1. Robert B. Lewis Director
    Sale
    $2.6M 65,068 shares at $40.61 57% of stake
    Traded Nov 17–20 Filed Nov 20
  2. Kimberly Irene Ulmer SVP & Chief Accounting Officer
    Buy
    $38K 1,000 shares at $38.11 +1% to stake
    Traded Nov 7, 2025 Filed Nov 10, 2025
  3. Adam J. Greenlee CEO
    Buy
    $267K 7,000 shares at $38.19 +2.2% to stake
    Traded Oct 31, 2025 Filed Nov 3, 2025

Also filed in the last 12 months, not counted as buying or selling: 21 stock grants and 8 share withholdings for taxes.

SEC filings

Recent issuer filings from EDGAR, 20 shown.

Filed Form Detail Links
SCHEDULE 13G —
8-K 1.01,9.01
10-Q
8-K 8.01,9.01
8-K 2.02,9.01
8-K 1.01,5.02,9.01
8-K 7.01,9.01
SCHEDULE 13G/A —
SCHEDULE 13G/A —
8-K 5.02
10-Q
8-K 8.01,9.01
8-K 2.02,9.01
SCHEDULE 13G —
8-K 5.02,5.07,9.01
8-K 8.01,9.01
10-Q
8-K 2.02,9.01
DEF 14A
SCHEDULE 13G/A —

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf